Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Vijayakumar M, Lemos PA, Hoye A, Ong AT, Aoki J, Granillo GR, McFadden EP, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Cummins PA, Serruys PW. Vijayakumar M, et al. Among authors: van domburg rt, van der giessen wj. Am J Cardiol. 2004 Oct 1;94(7):909-13. doi: 10.1016/j.amjcard.2004.06.036. Am J Cardiol. 2004. PMID: 15464675
Very long sirolimus-eluting stent implantation for de novo coronary lesions.
Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, Tanabe K, Lee CH, Hofma SJ, Sianos G, McFadden E, van der Giessen W, Smits PC, de Feyter PJ, van Domburg RT, Serruys PW. Degertekin M, et al. Am J Cardiol. 2004 Apr 1;93(7):826-9. doi: 10.1016/j.amjcard.2003.12.018. Am J Cardiol. 2004. PMID: 15050483 Free article. Clinical Trial.
Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial.
Kutryk MJ, Foley DP, van den Brand M, Hamburger JN, van der Giessen WJ, deFeyter PJ, Bruining N, Sabate M, Serruys PW; ITALICS Trial. Kutryk MJ, et al. Among authors: van den brand m, van der giessen wj. J Am Coll Cardiol. 2002 Jan 16;39(2):281-7. doi: 10.1016/s0735-1097(01)01741-7. J Am Coll Cardiol. 2002. PMID: 11788220 Free article. Clinical Trial.
Sirolimus-eluting coronary stents.
De Feyter PJ, Smits PC, Rensing BJ, Vos J, Van der Giessen WJ, Sianos G, Serruys PW. De Feyter PJ, et al. Among authors: van der giessen wj. J Interv Cardiol. 2002 Dec;15(6):467-70. doi: 10.1111/j.1540-8183.2002.tb01090.x. J Interv Cardiol. 2002. PMID: 12476649 No abstract available.
Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
Lemos PA, Lee CH, Degertekin M, Saia F, Tanabe K, Arampatzis CA, Hoye A, van Duuren M, Sianos G, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Lemos PA, et al. Among authors: van domburg rt, van duuren m, van der giessen wj. J Am Coll Cardiol. 2003 Jun 4;41(11):2093-9. doi: 10.1016/s0735-1097(03)00429-7. J Am Coll Cardiol. 2003. PMID: 12798587 Free article. Review.
Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy.
Saia F, Lemos PA, Sianos G, Degertekin M, Lee CH, Arampatzis CA, Hoye A, Tanabe K, Regar E, van der Giessen WJ, Smits PC, de Feyter P, Ligthart J, van Domburg RT, Serruys PW. Saia F, et al. Among authors: van domburg rt, van der giessen wj. Am J Cardiol. 2003 Jul 15;92(2):200-3. doi: 10.1016/s0002-9149(03)00538-1. Am J Cardiol. 2003. PMID: 12860224 Review. No abstract available.
295 results